Halozyme Therapeutics (HALO) stock valuation

$97.03 Nov 18, 2026 · market cap $12.0B

9/121 investors
i

Halozyme Therapeutics trades at $97. Our two models put it at $83–$350 (base $83): between them. The models disagree widely, so read the base with care.

Cash Flow $350 · Buffett $83 · models run Nov 18, 2026

9 of 121 tracked investors hold it · Q3 2026 13F filings

Estimates from SEC filings and market data; the verdict is AI research. Not investment advice. Get the iPhone app · Get the Android app

5 AI analysts debate HALOCreate free account →

Full open-source research report for HALO on DeepValues Research (CC BY 4.0)